Microbiology Of Ludwig’s Angina: Common Pathogens Involved
Published on: July 17, 2025
Microbiology Of Ludwig’s Angina: Common Pathogens Involved
Article author photo

Malvin Maneth

Bachelor of Science - BS, Biomedical Health, University of Derby

Article reviewer photo

Bethany Hayes

Integrated Masters in Biosciences

Introduction

Have you ever had a painful toothache that caused swelling under your jaw? For most people, it is just an uncomfortable dental issue, but in rare cases, that swelling can quickly turn dangerous. Ludwig’s Angina (LA) is a serious, fast-spreading bacterial infection that can become life-threatening without immediate treatment.

Despite its name, LA has nothing to do with the heart. Instead, it is a deep neck and oral cavity infection caused by a mix of harmful bacteria. Understanding how this infection develops, especially its microbiological roots, highlights why early diagnosis and rapid treatment are essential to preventing serious complications.

What is ludwig’s angina?

LA is a rare but dangerous soft tissue infection (cellulitis) that affects the floor of the mouth, under the tongue, and the space beneath the jaw. It spreads rapidly and can cause severe swelling, making it difficult to speak, swallow, or even breathe. The most critical risk is airway obstruction, which can occur quickly and may become fatal without prompt intervention. Although it can be triggered by mouth trauma or injuries, it most often stems from untreated dental infections, especially in the lower molars.1

Due to modern antibiotics and dental care, deaths from LA have significantly decreased. However, due to its rapid progression and the proximity to airway structures, it remains a medical emergency.

The microbial mix behind the infection

The infection in LA is typically polymicrobial, meaning it involves multiple types of bacteria. These include:2

Most of these bacteria are part of the body’s normal flora, living harmlessly in the mouth, but become opportunistic under certain conditions, such as dental infection, trauma, or weakened immunity, they invade deeper tissues and become pathogenic.3 

Which bacteria are involved?

Various bacteria work together to drive the rapid spread of LA, each contributing uniquely to the infection’s rapid progression and severity. Some of the most commonly identified pathogens are:2

Streptococcus species

Streptococcus species are among the most commonly isolated organisms in LA.

  • Viridans streptococcus: A facultative anaerobe that can survive with or without oxygen, plays a major role in early infection stages. Once inside deep tissues, it produces enzymes and adhesins that degrade connective tissue and modulate the immune response, creating conditions that allow other bacteria to thrive4
  • Streptococcus anginosus: infections involving S. anginosus are often more aggressive. It is well-known for forming abscesses and causing rapid tissue destruction, contributing to the dangerous progression of LA5

Anaerobic bacteria

Anaerobic bacteria often work alongside Streptococcus species to worsen the infection.

  • Fusobacterium necrophorum: Produces toxins and other virulence factors that promote tissue death (necrosis). In severe cases, it can enter the bloodstream and lead to systemic complications6
  • Bacteroides fragilis: produces beta-lactamase, an enzyme that breaks down certain antibiotics, making the infection harder to treat using standard antibiotics, and creates a supportive environment for other bacteria7
  • Peptostreptococcus species: often found in dental and deep neck infections, causes abscess formation8
  • Actinomyces species: a slow-growing but persistent organism that can cause chronic infections and may form part of biofilm communities9

Staphylococcus aureus

While less common than Streptococcus species, S. aureus, particularly its methicillin-resistant form (MRSA), may be involved in some cases of LA. This is more likely in individuals who:

  • Have compromised immune systems
  • Live with chronic illness
  • Have been recently hospitalised

MRSA-related LA poses treatment challenges due to resistance to standard antibiotics, often requiring tailored, more aggressive therapies.

Klebsiella pneumoniae

Though not a common resident of the oral cavity, K. pneumoniae is often isolated in LA cases involving diabetic patients, with some studies reporting its presence in over half of such cases.10,11

How do these bacteria work together?

The danger of LA is not just the presence of bacteria; it is how they interact. These microbes work in synergy, making the infection more severe:

  • Tissue breakdown: production of endotoxins like collagenase and hyaluronidase, proteases break down tissues and help the infection spread
  • Immune suppression: Some bacteria suppress immune responses or trick the body into ignoring them
  • Antibiotic protection: beta-lactamase-producing bacteria shield other organisms by neutralising antibiotics
  • Biofilms: Some bacteria form sticky protective layers that protect them from antibiotics and immune cells

This cooperative behaviour makes LA challenging to manage and highlights the need for aggressive, early treatment.

How clinicians identify the infection

LA is usually diagnosed during an emergency clinical assessment. Due to the risk of airway obstruction, clinicians prioritise physical symptoms over laboratory or imaging results. Key signs include:

  • Swelling on the floor of the mouth and jaw
  • Enlarged tongue
  • Difficulty speaking, breathing, or swallowing

In urgent cases, airway management begins immediately. Once the patient is stable, tests may include: 2

  • Blood cultures: to detect bacterial spread to the bloodstream
  • Ultrasound: to locate fluid collections or assess soft tissue involvement
  • CT scan with contrast: to evaluate the infection’s spread and detect any abscesses
  • Tissue and swab cultures: rarely performed due to the deep location and polymicrobial nature of the infection

Imaging is especially important for ruling out other conditions that mimic LA, such as tumours or abscesses from different causes.

Why the type of bacteria matters for treatment

Understanding the microbiology directly shapes how the condition is managed, especially in the early stages before lab results are available. Since the infection is polymicrobial, empirical treatment is guided by the typical organisms known to be involved. 2

What antibiotics are used?

Once the airway is secured, patients are given broad-spectrum antibiotics intravenously (IV). These include:

These choices are based on the known microbial profile of LA and aim to prevent further deterioration while awaiting culture results.

What else is done to treat it?

Adjuvant treatments like IV corticosteroids are sometimes used to reduce swelling and help antibiotics penetrate infected tissues. If abscesses are identified or antibiotics are ineffective, surgical drainage may be necessary, especially in cases involving S. anginosus or F. necrophorum.

Understanding the likely organisms that are involved helps guide decisions about:

  • Whether to escalate antibiotic treatment
  • How long should therapy continue for
  • Whether surgery is required

Why does this knowledge help, even after treatment

  • Preventing recurrence: Chronic infections caused by Actinomyces may require prolonged treatment or follow-up
  • Predicting complications: Infections involving F. necrophorum are more likely to lead to systemic conditions
  • Monitoring at-risk individuals: Immunocompromised and diabetic patients are more prone to infections involving K. pneumoniae and MRSA

In addition, understanding how these bacteria form biofilms or secrete enzymes can explain why some infections do not respond as expected, guiding clinicians to escalate care earlier.

Summary

Ludwig’s Angina is a rare but potentially life-threatening infection that affects the floor of the mouth and neck. It usually starts from a dental infection and involves a combination of bacteria that work together to invade deep tissues and suppress the immune system. Understanding the microbiology behind the infection is vital for early and effective treatment. Since it progresses rapidly and involves multiple bacteria, clinicians begin with broad-spectrum antibiotics and may perform surgical drainage if necessary. Identifying the likely organisms also helps prevent complications and guides decisions on long-term care, especially for high-risk patients. Thanks to advances in microbiology and emergency care, LA can now be treated effectively, but only if caught early. Recognising the bacteria involved can mean the difference between full recovery and life-threatening complications.

FAQs

Is LA contagious?

No, it is caused by bacteria that are normally present in the mouth and become harmful when dental problems go untreated. It does not spread from one person to another.

How fast does it progress?

Very quickly. LA can worsen within hours, swelling may increase rapidly and obstruct the airway, making it a medical emergency that requires immediate treatment.

Can it be prevented?

Yes, good oral hygiene and timely dental care can help prevent the condition. Treating dental infections early, especially in the lower molars, greatly reduces the risk. Individuals with diabetes or weakened immune systems should also manage their conditions closely.

References

  1. Bridwell R, Gottlieb M, Koyfman A, Long B. Diagnosis and management of Ludwig’s angina: An evidence-based review. The American Journal of Emergency Medicine [Internet]. Elsevier BV; 2020 [cited 2025 Jun 1]; 41:1–5. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0735675720311499.
  2. An J, AL Ghabra Y, Singhal M. Ludwig Angina. In: Nih.gov [Internet]. StatPearls Publishing; 2023 [cited 2025 Jun 1]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482354/.
  3. Gaetti-Jardim Jr E, Landucci LF, De Oliveira KL, Costa I, Ranieri RV, Okamoto AC, et al. Microbiota Associated with Infections of the Jaws. International Journal of Dentistry [Internet]. Hindawi Publishing Corporation; 2012 [cited 2025 Jun 5]; 2012:1–8. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3399405/.
  4. Yumoto H, Hirota K, Hirao K, Ninomiya M, Murakami K, Fujii H, et al. The Pathogenic Factors from Oral Streptococci for Systemic Diseases. International Journal of Molecular Sciences [Internet]. MDPI AG; 2019 [cited 2025 Jun 9]; 20(18):4571. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6770522/.
  5. Pilarczyk-Zurek M, Sitkiewicz I, Koziel J. The Clinical View on Streptococcus anginosus Group – Opportunistic Pathogens Coming Out of Hiding. Frontiers in Microbiology [Internet]. Frontiers Media; 2022 [cited 2025 Jun 9]; 13. Available from: https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2022.956677/full.
  6. Tan ZL, Nagaraja TG, Chengappa MM. Fusobacterium necrophorum infections: Virulence factors, pathogenic mechanism and control measures. Veterinary Research Communications [Internet]. Springer Science+Business Media; 1996 [cited 2025 Jun 10]; 20(2):113–40. Available from: https://link.springer.com/article/10.1007/BF00385634.
  7. Elsaghir H, Reddivari AKR. Bacteroides Fragilis. In: nih.gov [Internet]. StatPearls Publishing; 2023 [cited 2025 Jun 10]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK553032/.
  8. Yang S-W, Lee M-H, See L-C, Huang S-H, Chen T-M, Chen T-A. Deep neck abscess: an analysis of microbial etiology and the effectiveness of antibiotics. Infection and Drug Resistance [Internet]. Dove Medical Press; 2008 [cited 2025 Jun 10]; 1–1. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3108716/.
  9. Sharma S, Hashmi MF, Valentino III DJ. Actinomycosis. In: Nih.gov [Internet]. StatPearls Publishing; 2023 [cited 2025 Jun 10]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482151/.
  10. Chang CM, Lu FH, Guo HR, Ko WC. Klebsiella pneumoniae fascial space infections of the head and neck in Taiwan: emphasis on diabetic patients and repetitive infections. Journal of Infection [Internet]. Elsevier BV; 2005 [cited 2025 Jun 9]; 50(1):34–40. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0163445303002275.
  11. Kamat RD, Dhupar V, Akkara F, Shetye O. A comparative analysis of odontogenic maxillofacial infections in diabetic and nondiabetic patients: an institutional study. Journal of the Korean Association of Oral and Maxillofacial Surgeons [Internet]. Korean Association of Oral and Maxillofacial Surgeons; 2015 [cited 2025 Jun 9]; 41(4):176–6. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4558185/.
Share

Malvin Maneth

Bachelor of Science (Honours) in Biomedical Health

arrow-right